A Randomized, Open-Label Study of Daclatasvir and Sofosbuvir With or Without Ribavirin for 8 Weeks in Treatment-Naïve, Non-cirrhotic Subjects Infected With Chronic Hepatitis C Virus (HCV) Genotype 3

Local Institution, Pessac

Local Institution, Montpellier

Local Institution, Vandœuvre-lès-Nancy

Local Institution, Paris

Local Institution, Limoges

Local Institution, Créteil

Local Institution, Calgary

Local Institution, Edmonton

Local Institution, Vancouver

Local Institution, Vancouver

Local Institution, Victoria

Local Institution, Toronto